-
Published01/12/2018
-
Awarded10/12/2018
-
Deadline10/03/2019
-
Opening of tenders10/05/2019
-
Today01/09/2026
Utilities
- indicates text translated automatically in your browsing language
Germany-Düsseldorf: Pharmaceutical products
Paragraph 130a(8) of the SGB V allows health insurance funds (KK) and pharmaceutical companies to conclude framework discount agreements for the medicinal products to be supplied at the expense of the statutory KK.
GWQ operates as a company for economic viability and quality at KK in accordance with the fifth sentence of Section 130a(8) of the SGB V for its shareholder and customer funds. With regard to the relevant legal provisions on public procurement, a regular process of active-related, formal procurement procedures are carried out by GWQ ServicePlus AG in accordance with the rules of Part 4 of the GWB. Until the entry into force of new drug rebate agreements, GWQ wishes to enter into agreements with all interested pharmaceutical companies, in the context of the open-house procedure, for medicinal products with the active ingredient opipramol in the active strengths of 50 mg and 100 mg. The earliest contract starts on 01/01/2019.
Official name: GWQ ServicePlus AG
Postal address: GWQ ServicePlus AG, Tersteegenstraße 28, 40474 Düsseldorf, handelnd für die unter VI 2.) näher genannten Gesetzlichen Krankenkassen
Town: Düsseldorf
NUTS code: DE
Postal code: 40474
Country: DEU
Main address: http://www.gwq-serviceplus.de
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.